Dataset opportunity
Hannonpharmalink — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Hannonpharmalink, usable for Regulatory RAG and Compliance Copilots.
Score
70
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global pharmaceutical logistics market size was valued at USD 80.56 billion in 2025, projected to exhibit a CAGR of 7.90%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 📣Press / announcement
Investment in specialized refrigerated fleet with integrated tracking
source ↗
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
mobility
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
RegTech & compliance-AI vendors
Hannonpharmalink provides a Regulatory Records Dataset in Text modality, compiled from a rich mix of APIs, event streams, IoT data, and formal regulatory filings. This data offers a granular, evidence-based view of pharmaceutical logistics operations, making it exceptionally suited for a Regulatory RAG use case by enabling an AI to retrieve and synthesize precise compliance and operational answers from complex, multi-format source material.
The global pharmaceutical logistics market was valued at USD 80.56 billion in 2025 and is projected to grow at a CAGR of 7.90%. [2] This dataset's value is amplified by its rare combination of sensitive pharmaceutical supply chain information and temperature-controlled logistics logs, which are subject to strict GDP compliance. While access requires group-level approval from Hannon Group, the data's depth and direct applicability to high-value AI compliance automation make it a compelling asset for sophisticated buyers. ⚠ Diligence (valuable data, access to negotiate): Data includes sensitive pharmaceutical supply chain information.; Temperature-controlled logistics logs are subject to strict regulatory compliance (GDP).; Part of the larger Hannon Group, requiring group-level data sharing approval. · corporate: subsidiary of Hannon Group.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Hannonpharmalink holds a proprietary dataset detailing the complete lifecycle of pharmaceutical shipments, including regulatory compliance records, real-time IoT sensor data, and end-to-end event streams. For RegTech and compliance-AI vendors, this is a rare source of ground-truth data essential for training Regulatory RAG models that can automate audits and ensure GDP compliance. In a pharmaceutical logistics market projected to grow at nearly 8% annually, this dataset offers a significant competitive edge by enabling next-generation compliance solutions.
See dimension details ↓- ICP Audit100
✓ good target — This is a perfect target: a specialized logistics SME with a real operational business and its own fleet, generating proprietary, dormant data as a by-product of its core transport services.
- Deep Qualification90
⚠ needs review — Hannonpharmalink is a logistics service provider, not a data seller; the data, likely owned by its clients, is a plausible but highly restricted byproduct of its regulated transport operations. [data is owned by the company's customers; licensing restricted]
- Dataset Specificity90
dominant 'regulatory', sector mobility, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand80
AI buyer demand is strong, driven by the need to automate compliance and enhance efficiency in the rapidly growing pharmaceutical logistics market (CAGR of 7.90%). [2]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility32
open/API access
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
medium difficulty, subsidiary of Hannon Group
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 evidence types, 4 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
subsidiary of Hannon Group
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
API access
This evidence points to documentation for a quality management system for handling Active Pharmaceutical Ingredients, a critical component for any vendor serving the regulated pharmaceutical supply chain.
IoT / sensor data
The company generates valuable time-series data from its real-time temperature monitoring and GPS tracking systems, which is essential for cold chain validation and risk management applications.
Regulatory records
This text-based dataset contains the traceability records and audit trails necessary to prove compliance with Good Distribution Practice (GDP), directly feeding regulatory reporting and AI-powered compliance models.
Event streams
The holder captures detailed event streams that provide end-to-end visibility of shipment movements, offering granular data on transit times and logistics handoffs for supply chain optimization models.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Hannonpharmalink Regulatory Records — a Moderate regulatory records dataset (Text modality) in the mobility domain. Primary AI use-case: Regulatory RAG. Market signal: Global pharmaceutical logistics market size was valued at USD 80.56 billion in 2025, projected to exhibit a CAGR of 7.90% (source: Spherical Insights LLP). Investment score 70.0/100 (confidence 0.56). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Shapiro — Regulatory Records Dataset Opportunity
View opportunity →otherAltus Renewables — Regulatory Records Dataset Opportunity
View opportunity →mobilityFlex — Mobility Telemetry Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read
- Why Buy External Data?3 min read